Position in EVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$100,181
+$14,864 QoQ
Shares Held
35,779
+4.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 34 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pathstone Holdings, LLC holds $42,015,720 across 17 Drug Manufacturers - Specialty & Generic names. EVO ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
273,446 | $6,729,505 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
177,906 | $6,027,454 | |
| 3 | ZTS |
Zoetis Inc.
|
74,081 | $5,323,460 | |
| 4 | ALKS |
Alkermes plc.
|
82,327 | $4,313,934 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
239,306 | $3,836,074 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
5,129 | $2,779,045 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
70,526 | $2,445,136 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
13,005 | $2,191,862 |
All Filings in EVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $100,181 | 35,779 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $85,317 | 34,127 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||